APRINOIA Therapeutics Licenses Tau PET Imaging Tracer APN-1607 to Celgene
TAIPEI, Taiwan, Jan. 2, 2019 /PRNewswire/ — APRINOIA Therapeutics, a clinical-stage biotechnology company developing therapeutics and diagnostic imaging tools for neurodegenerative diseases announced today that it has entered into a…